{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:13:35Z","timestamp":1794464015716,"version":"4.9.1"},"reference-count":131,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.heliyon.2023.e20507","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T21:43:38Z","timestamp":1695937418000},"page":"e20507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Don't eat me\/eat me signals as a novel strategy in cancer immunotherapy"],"prefix":"10.1016","volume":"9","author":[{"given":"Amirreza","family":"Khalaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatereh Baharlouei","family":"Yancheshmeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Farham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Khorram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Sheshbolouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zokaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Vatankhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6478-3951","authenticated-orcid":false,"given":"Mehdi","family":"Soleymani-Goloujeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2023.e20507_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: a cancer journal for clinicians"},{"key":"10.1016\/j.heliyon.2023.e20507_bib2","series-title":"Country and by Region, 2000\u20102019","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e20507_bib3","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.2147\/OTT.S249822","article-title":"Potential new cancer immunotherapy: anti-CD47-SIRP\u03b1 antibodies","volume":"13","author":"Lu","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib4","doi-asserted-by":"crossref","DOI":"10.1142\/S1793545816300019","article-title":"Photonics immunotherapy\u2014a novel strategy for cancer treatment","volume":"9","author":"Zhou","year":"2016","journal-title":"Journal of Innovative Optical Health Sciences"},{"key":"10.1016\/j.heliyon.2023.e20507_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Origins and hallmarks of macrophages: development, homeostasis, and disease","volume":"496","author":"Ta","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/ijms19010092","article-title":"The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis","volume":"19","author":"Hirayama","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cub.2020.09.082","article-title":"An acquired and endogenous glycocalyx forms a bidirectional \u201cDon't Eat\u201d and \u201cDon't Eat Me\u201d barrier to phagocytosis","volume":"31","author":"Imbert","year":"2021","journal-title":"Curr. Biol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20507_bib8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","article-title":"Phagocytosis checkpoints as new targets for cancer immunotherapy","volume":"19","author":"Feng","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20507_bib9","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202152564","article-title":"Putting the brakes on phagocytosis:\u201cdon't\u2010eat\u2010me\u201d signaling in physiology and disease","volume":"22","author":"Kelley","year":"2021","journal-title":"EMBO Rep."},{"issue":"7769","key":"10.1016\/j.heliyon.2023.e20507_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e20507_bib11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1189\/jlb.1005550","article-title":"Recognition ligands on apoptotic cells: a perspective","volume":"79","author":"Gardai","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20507_bib12","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202152564","article-title":"Putting the brakes on phagocytosis: \"don't-eat-me\" signaling in physiology and disease","volume":"22","author":"Kelley","year":"2021","journal-title":"EMBO Rep."},{"key":"10.1016\/j.heliyon.2023.e20507_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fimmu.2020.00553","article-title":"Phagocytosis of apoptotic cells in resolution of inflammation","volume":"11","author":"Kourtzelis","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2353\/ajpath.2007.070135","article-title":"Immunological consequences of apoptotic cell phagocytosis","volume":"171","author":"Erwig","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e20507_bib15","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1084\/jem.20101157","article-title":"Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums","volume":"207","author":"Ravichandran","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.heliyon.2023.e20507_bib16","first-page":"1","article-title":"Biological membranes architecture and function","volume":"1","author":"Sackmann","year":"1995","journal-title":"Structure and dynamics of membranes"},{"issue":"16","key":"10.1016\/j.heliyon.2023.e20507_bib17","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJMra0901217","article-title":"Cell death","volume":"361","author":"Hotchkiss","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e20507_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.cellbio.20.022003.114619","article-title":"The engulfment process of programmed cell death in Caenorhabditis elegans","volume":"20","author":"Reddien","year":"2004","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20507_bib19","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1378\/chest.129.6.1673","article-title":"Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease","volume":"129","author":"Vandivier","year":"2006","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e20507_bib20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.immuni.2011.09.004","article-title":"Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways","volume":"35","author":"Ravichandran","year":"2011","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20507_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1097-2765(04)00237-0","article-title":"Clearance of apoptotic cells: getting rid of the corpses","volume":"14","author":"Lauber","year":"2004","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e20507_bib22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.cell.2010.02.014","article-title":"Autoimmunity and the clearance of dead cells","volume":"140","author":"Nagata","year":"2010","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e20507_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/10409230903193307","article-title":"The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease","volume":"44","author":"Fadeel","year":"2009","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20507_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nri3607","article-title":"Apoptotic cell clearance: basic biology and therapeutic potential","volume":"14","author":"Poon","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-065X.2008.00666.x","article-title":"Immunoreceptor tyrosine\u2010based inhibition motifs: a quest in the past and future","volume":"224","author":"Da\u00ebron","year":"2008","journal-title":"Immunol. Rev."},{"issue":"5489","key":"10.1016\/j.heliyon.2023.e20507_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.290.5489.84","article-title":"Immune inhibitory receptors","volume":"290","author":"Ravetch","year":"2000","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20507_bib27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","article-title":"The \u2018Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling","volume":"28","author":"Neel","year":"2003","journal-title":"Trends Biochem. Sci."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20507_bib28","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1128\/MCB.20.10.3576-3589.2000","article-title":"Essential role for the C-terminal noncatalytic region of SHIP in Fc\u03b3RIIB1-mediated inhibitory signaling","volume":"20","author":"Aman","year":"2000","journal-title":"Molecular and cellular biology"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/imr.12336","article-title":"Of ITIM s, ITAM s, and ITAM is: revisiting immunoglobulin Fc receptor signaling","volume":"268","author":"Getahun","year":"2015","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-065X.2008.00760.x","article-title":"SHP\u20101 and SHP\u20102 in T cells: two phosphatases functioning at many levels","volume":"228","author":"Lorenz","year":"2009","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e20507_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.heliyon.2023.e20507_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Contr. Release"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20507_bib33","first-page":"996","volume":"14","author":"Jenne","year":"2013","journal-title":"Immune surveillance by the liver"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20507_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1189\/jlb.72.2.239","article-title":"Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections","volume":"72","author":"Gregory","year":"2002","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1806444","article-title":"A combined \"eat me\/don't eat me\" strategy based on extracellular vesicles for anticancer nanomedicine","volume":"9","author":"Belhadj","year":"2020","journal-title":"J. Extracell. Vesicles"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20507_bib36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","article-title":"Phagocytosis checkpoints as new targets for cancer immunotherapy","volume":"19","author":"Feng","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.heliyon.2023.e20507_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"18","key":"10.1016\/j.heliyon.2023.e20507_bib38","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.7150\/thno.56936","article-title":"An \"eat me\" combinatory nano-formulation for systemic immunotherapy of solid tumors","volume":"11","author":"Abdel-Bar","year":"2021","journal-title":"Theranostics"},{"issue":"46","key":"10.1016\/j.heliyon.2023.e20507_bib39","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1038\/onc.2016.104","article-title":"Damage-associated molecular patterns in cancer: a double-edged sword","volume":"35","author":"Hernandez","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat Med"},{"issue":"63","key":"10.1016\/j.heliyon.2023.e20507_bib41","doi-asserted-by":"crossref","first-page":"63ra94","DOI":"10.1126\/scitranslmed.3001375","article-title":"Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47","volume":"2","author":"Chao","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20507_bib42","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/1878-0261.12556","article-title":"Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell 'don't eat me' signals off and 'eat me' signals on","volume":"13","author":"Mohanty","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.heliyon.2023.e20507_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fcell.2018.00038","article-title":"Targeting tumor-associated macrophages as a potential strategy to enhance the response to immune checkpoint inhibitors","volume":"6","author":"Cassetta","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e20507_bib44","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1200\/JCO.18.02018","article-title":"First-in-Human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers","volume":"37","author":"Sikic","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e20507_bib45","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat Med"},{"issue":"17","key":"10.1016\/j.heliyon.2023.e20507_bib46","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.1121629109","article-title":"Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma","volume":"109","author":"Edris","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"10.1016\/j.heliyon.2023.e20507_bib47","doi-asserted-by":"crossref","first-page":"23662","DOI":"10.18632\/oncotarget.4282","article-title":"CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models","volume":"6","author":"Xu","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12951-020-00684-5","article-title":"Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme","volume":"18","author":"Choi","year":"2020","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.heliyon.2023.e20507_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2016.01.009","volume":"99","author":"Bagalkot","year":"2016","journal-title":"Eat me\" imaging and therapy. Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/tra.12233","article-title":"Role of flippases, scramblases and transfer proteins in phosphatidylserine subcellular distribution","volume":"16","author":"Hankins","year":"2015","journal-title":"Traffic"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20507_bib51","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nri3607","article-title":"Apoptotic cell clearance: basic biology and therapeutic potential","volume":"14","author":"Poon","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20507_bib52","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2016.08.015","article-title":"Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species","volume":"45","author":"Guilliams","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/imr.12587","article-title":"Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment","volume":"280","author":"Kumar","year":"2017","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20507_bib54","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00281-018-0698-5","article-title":"Efferocytosis in the tumor microenvironment","volume":"40","author":"Werfel","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.heliyon.2023.e20507_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4939-2703-6_10","article-title":"Using phosphatidylserine exposure on apoptotic cells to stimulate myoblast fusion","volume":"1313","author":"Hochreiter-Hufford","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e20507_bib56","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/35046549","article-title":"alphavbeta5 integrin recruits the CrkII-Dock180-rac1 complex for phagocytosis of apoptotic cells","volume":"2","author":"Albert","year":"2000","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e20507_bib57","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1095\/biolreprod.107.065045","article-title":"Epithelial cells remove apoptotic epithelial cells during post-lactation involution of the mouse mammary gland","volume":"78","author":"Monks","year":"2008","journal-title":"Biol. Reprod."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e20507_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/boc.201500090","article-title":"Efferocytosis of apoptotic human papillomavirus-positive cervical cancer cells by human primary fibroblasts","volume":"108","author":"Hermetet","year":"2016","journal-title":"Biol Cell"},{"issue":"7261","key":"10.1016\/j.heliyon.2023.e20507_bib59","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20507_bib60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2005.08.032","article-title":"Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte","volume":"123","author":"Gardai","year":"2005","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib61","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/s41467-019-12406-z","article-title":"Phosphatidylserine on viable sperm and phagocytic machinery in oocytes regulate mammalian fertilization","volume":"10","author":"Rival","year":"2019","journal-title":"Nat. Commun."},{"issue":"6 Pt 1","key":"10.1016\/j.heliyon.2023.e20507_bib62","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1083\/jcb.111.6.2785","article-title":"Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins","volume":"111","author":"Brown","year":"1990","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20507_bib63","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1083\/jcb.123.2.485","article-title":"Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding","volume":"123","author":"Lindberg","year":"1993","journal-title":"J. Cell Biol."},{"issue":"5473","key":"10.1016\/j.heliyon.2023.e20507_bib64","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"issue":"39","key":"10.1016\/j.heliyon.2023.e20507_bib65","doi-asserted-by":"crossref","first-page":"26613","DOI":"10.1074\/jbc.M109.017566","article-title":"Structure of signal-regulatory protein alpha: a link to antigen receptor evolution","volume":"284","author":"Hatherley","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20507_bib66","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.heliyon.2023.e20507_bib67","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1073\/pnas.1121623109","article-title":"The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"109","author":"Willingham","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20507_bib68","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/annonc\/mdz006","article-title":"The Macrophage 'Don't eat me' signal, CD47, is a clinically validated cancer immunotherapy target","volume":"30","author":"Takimoto","year":"2019","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e20507_bib69","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.4049\/jimmunol.160.7.3562","article-title":"Regulation of macrophage phagocytosis of apoptotic cells by cAMP","volume":"160","author":"Rossi","year":"1998","journal-title":"The journal of immunology"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e20507_bib70","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41577-019-0167-y","article-title":"How macrophages deal with death","volume":"19","author":"Lemke","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20507_bib71","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/cdd.2016.13","article-title":"Do not let death do us part:\u2018find-me\u2019signals in communication between dying cells and the phagocytes","volume":"23","author":"Medina","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.heliyon.2023.e20507_bib72","first-page":"2144","article-title":"The phagocytic code regulating phagocytosis of mammalian cells","author":"Cockram","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib73","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41590-017-0004-z","article-title":"Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy","volume":"19","author":"Barkal","year":"2018","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e20507_bib74","first-page":"2741","article-title":"Signal-regulatory protein \u03b1 (SIRP\u03b1) but not SIRP\u03b2 is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34+ CD38\u2212 hematopoietic cells. Blood","volume":"97","author":"Seiffert","year":"2001","journal-title":"The Journal of the American Society of Hematology"},{"key":"10.1016\/j.heliyon.2023.e20507_bib75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2020.00018","article-title":"Advances in anti-tumor treatments targeting the CD47\/SIRP\u03b1 axis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12527","article-title":"The CD47\u2010SIRP\u03b1 signaling axis as an innate immune checkpoint in cancer","volume":"276","author":"Matlung","year":"2017","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20507_bib77","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.coi.2012.01.010","article-title":"The CD47\u2013SIRP\u03b1 pathway in cancer immune evasion and potential therapeutic implications","volume":"24","author":"Chao","year":"2012","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e20507_bib78","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","article-title":"The CD47-SIRP\u03b1 immune checkpoint","volume":"52","author":"Logtenberg","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2023.e20507_bib79","doi-asserted-by":"crossref","first-page":"37984","DOI":"10.1074\/jbc.M002334200","article-title":"CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation","volume":"275","author":"Han","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2023.e20507_bib80","first-page":"2130","article-title":"CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPalpha 1","volume":"30","author":"Vernon-Wilson","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.heliyon.2023.e20507_bib81","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2023.e20507_bib82","article-title":"Pre-clinical development of a humanized anti-CD47 antibody with anti-cancer therapeutic potential","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e20507_bib83","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1238856","article-title":"Engineered SIRPalpha variants as immunotherapeutic adjuvants to anticancer antibodies","volume":"341","author":"Weiskopf","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2023.e20507_bib84","article-title":"TTI-621 (SIRPalphaFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e20507_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14802","article-title":"A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer","volume":"8","author":"Betancur","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20507_bib86","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1158\/2326-6066.CIR-18-0222","article-title":"Late-stage tumor regression after PD-L1 blockade plus a concurrent OX40 AgonistLarge tumors regress with anti\u2013PD-L1 and anti-OX40 treatment","volume":"7","author":"Polesso","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"479","key":"10.1016\/j.heliyon.2023.e20507_bib87","doi-asserted-by":"crossref","first-page":"eaat1500","DOI":"10.1126\/scitranslmed.aat1500","article-title":"Human tumor-associated monocytes\/macrophages and their regulation of T cell responses in early-stage lung cancer","volume":"11","author":"Singhal","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20507_bib88","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/2326-6066.CIR-17-0537","article-title":"Programmed cell death ligand 1 (PD-L1) signaling regulates macrophage proliferation and ActivationPD-L1 regulates macrophage proliferation and activation","volume":"6","author":"Hartley","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20507_bib89","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.yexcr.2017.08.028","article-title":"Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma","volume":"359","author":"Zhang","year":"2017","journal-title":"Experimental cell research"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e20507_bib90","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.4049\/jimmunol.159.11.5192","article-title":"A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules","volume":"159","author":"Borges","year":"1997","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e20507_bib91","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00262-017-2023-x","article-title":"LILRB receptor-mediated regulation of myeloid cell maturation and function","volume":"66","author":"van der Touw","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20507_bib92","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jmb.2005.10.057","article-title":"Entropically driven MHC class I recognition by human inhibitory receptor leukocyte Ig-like receptor B1 (LILRB1\/ILT2\/CD85j)","volume":"355","author":"Shiroishi","year":"2006","journal-title":"Journal of molecular biology"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e20507_bib93","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/eji.201546149","article-title":"Interaction of the LILRB1 inhibitory receptor with HLA class Ia dimers","volume":"46","author":"Ba\u00eda","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e20507_bib94","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12804","article-title":"The MHC class I\u2010LILRB1 signalling axis as a promising target in cancer therapy","volume":"90","author":"Zhao","year":"2019","journal-title":"Scand. J. Immunol."},{"issue":"7755","key":"10.1016\/j.heliyon.2023.e20507_bib95","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41586-019-1104-8","article-title":"The bone marrow microenvironment at single-cell resolution","volume":"569","author":"Tikhonova","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e20507_bib96","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00418-016-1531-7","article-title":"Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal\u2013maternal interface","volume":"147","author":"Sammar","year":"2017","journal-title":"Histochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e20507_bib97","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/glycob\/cwu068","article-title":"Siglec-G\/10 in self\u2013nonself discrimination of innate and adaptive immunity","volume":"24","author":"Chen","year":"2014","journal-title":"Glycobiology"},{"key":"10.1016\/j.heliyon.2023.e20507_bib98","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3389\/fimmu.2020.01324","article-title":"Molecular mechanism of tumor cell immune escape mediated by CD24\/Siglec-10","volume":"11","author":"Yin","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20507_bib99","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4049\/jimmunol.160.2.831","article-title":"Distinct patterns of folding and interactions with calnexin and calreticulin in human class I MHC proteins with altered N-glycosylation","volume":"160","author":"Zhang","year":"1998","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e20507_bib100","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.4049\/jimmunol.160.11.5404","article-title":"Calreticulin and calnexin interact with different protein and glycan determinants during the assembly of MHC class I","volume":"160","author":"Harris","year":"1998","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e20507_bib101","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.4049\/jimmunol.1300057","article-title":"Bruton's tyrosine kinase is required for apoptotic cell uptake via regulating the phosphorylation and localization of calreticulin","volume":"190","author":"Byrne","year":"2013","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20507_bib102","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10495-019-01532-0","article-title":"Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes","volume":"24","author":"Schcolnik-Cabrera","year":"2019","journal-title":"Apoptosis"},{"key":"10.1016\/j.heliyon.2023.e20507_bib103","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2018.10.020","article-title":"SLAMF receptors on normal and malignant B cells","volume":"204","author":"Shachar","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.heliyon.2023.e20507_bib104","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev.immunol.021908.132554","article-title":"The ins and outs of leukocyte integrin signaling","volume":"27","author":"Abram","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2023.e20507_bib105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.immunol.17.1.593","article-title":"Mechanisms of phagocytosis in macrophages","volume":"17","author":"Aderem","year":"1999","journal-title":"Annu. Rev. Immunol."},{"issue":"7651","key":"10.1016\/j.heliyon.2023.e20507_bib106","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature22076","article-title":"SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin","volume":"544","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2023.e20507_bib107","series-title":"Fc Receptor-dependent Mechanisms of Monoclonal Antibody Therapy of Cancer","author":"Bakema","year":"2014"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib108","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2023.e20507_bib109","series-title":"Fc Receptor Biology","first-page":"203","author":"Daeron","year":"1997"},{"key":"10.1016\/j.heliyon.2023.e20507_bib110","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e20507_bib111","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm.2017.138","article-title":"Understanding the diversity of membrane lipid composition","volume":"19","author":"Harayama","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2023.e20507_bib112","series-title":"Molecular Biology of the Cell","author":"Alberts","year":"2017"},{"issue":"61","key":"10.1016\/j.heliyon.2023.e20507_bib113","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/newbio236011a0","article-title":"Asymmetrical lipid bilayer structure for biological membranes","volume":"236","author":"Bretscher","year":"1972","journal-title":"Nat. New Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e20507_bib114","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.4049\/jimmunol.180.4.2329","article-title":"C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition","volume":"180","author":"Paidassi","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20507_bib115","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1152\/physrev.00020.2015","article-title":"Getting to the outer leaflet: physiology of phosphatidylserine exposure at the plasma membrane","volume":"96","author":"Bevers","year":"2016","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20507_bib116","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3390\/s110201744","article-title":"Sensing phosphatidylserine in cellular membranes","volume":"11","author":"Kay","year":"2011","journal-title":"Sensors"},{"key":"10.1016\/j.heliyon.2023.e20507_bib117","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0021-9258(18)57326-9","article-title":"The chemical structure of phosphatidyl serine","volume":"174","author":"Folch","year":"1948","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2023.e20507_bib118","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev.biophys.093008.131234","article-title":"The distribution and function of phosphatidylserine in cellular membranes","volume":"39","author":"Leventis","year":"2010","journal-title":"Annu. Rev. Biophys."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e20507_bib119","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1134\/S0006297922030014","article-title":"Apoptotic features in non-apoptotic processes","volume":"87","author":"Savitskaya","year":"2022","journal-title":"Biochemistry (Mosc.)"},{"issue":"20","key":"10.1016\/j.heliyon.2023.e20507_bib120","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.7150\/thno.45125","article-title":"Targeting phosphatidylserine for Cancer therapy: prospects and challenges","volume":"10","author":"Chang","year":"2020","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e20507_bib121","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.4049\/jimmunol.148.7.2207","article-title":"Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages","volume":"148","author":"Fadok","year":"1992","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e20507_bib122","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12964-019-0437-0","article-title":"Flipping the dogma - phosphatidylserine in non-apoptotic cell death","volume":"17","author":"Shlomovitz","year":"2019","journal-title":"Cell Commun. Signal."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e20507_bib123","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/cr.2013.115","article-title":"Mechanisms of apoptotic phosphatidylserine exposure","volume":"23","author":"Marino","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.heliyon.2023.e20507_bib124","series-title":"Biochemistry of Lipids, Lipoproteins and Membranes","first-page":"457","article-title":"Inter-and intra-membrane lipid transport","author":"Vesa","year":"2021"},{"issue":"19","key":"10.1016\/j.heliyon.2023.e20507_bib125","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.4161\/15384101.2014.962865","article-title":"Flippases and scramblases in the plasma membrane","volume":"13","author":"Segawa","year":"2014","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e20507_bib126","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/cdd.2016.7","article-title":"Exposure of phosphatidylserine on the cell surface","volume":"23","author":"Nagata","year":"2016","journal-title":"Cell Death Differ."},{"issue":"48","key":"10.1016\/j.heliyon.2023.e20507_bib127","doi-asserted-by":"crossref","first-page":"19246","DOI":"10.1073\/pnas.1114799108","article-title":"Constitutive exposure of phosphatidylserine on viable cells","volume":"108","author":"Segawa","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.heliyon.2023.e20507_bib128","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3389\/fimmu.2019.00962","article-title":"Macrophages do not express the phagocytic receptor Bai1\/ADGRB1","volume":"10","author":"Hsiao","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20507_bib129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1242\/jcs.018093","article-title":"Integrin signalling at a glance","volume":"122","author":"Harburger","year":"2009","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e20507_bib130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yexcr.2016.08.009","article-title":"Involvement of Tiam1, RhoG and ELMO2\/ILK in Rac1-mediated phagocytosis in human trabecular meshwork cells","volume":"347","author":"Peotter","year":"2016","journal-title":"Experimental cell research"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e20507_bib131","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1042\/BST20211254","article-title":"Dynamics of phagocytosis mediated by phosphatidylserine","volume":"50","author":"Vorselen","year":"2022","journal-title":"Biochem. Soc. Trans."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023077150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023077150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:13:54Z","timestamp":1790756034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023077150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":131,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2405844023077150"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20507","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Don't eat me\/eat me signals as a novel strategy in cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e20507"}}